Aspen Neuroscience Gets $70 Million Series A Funding Round
Tuesday, April 14, 2020
Photo courtesy of Aspen Neuroscience. Laboratory workers at Aspen Neuroscience work on Parkinson’s disease treatments.
Aspen Neuroscience, a private biotech company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, announced the close of its Series A funding round of $70 million...